Multicenter Prospective Observational Study Evaluating the Management of Heart Failure
NCT ID: NCT05180370
Last Updated: 2023-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2021-03-15
2022-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study on Disease Awareness and Treatment Compliance of Heart Failure Patients
NCT05180396
Multiple-biomarker Approach for Individualized Treatment of Heart Failure with Preserved Ejection Fraction
NCT06785506
Web-based Training and Telephone Follow-up of Patients With Heart Failure: Randomized Controlled Trial
NCT04210167
Patient Journey in Hospital With Heart Failure in Turkish Population
NCT02487056
Multiparametric Assessment of Cardiac Congestion in Outpatient Worsening Heart Failure
NCT05747820
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Outpatient or inpatient diagnosed with Heart Failure at least 6 months ago
ADAPTATION HF is a prospective, observational, cross-sectional, multicenter, survey-based study. Patients who applied to the cardiology outpatient clinic with a preliminary diagnosis of HF or were hospitalized for HF and had a diagnosis of HF for at least 6 months will be included in the study.
Questionnaies
Data entry staff who will be assigned to the centers for 2 weeks will apply a questionnaire consisting of different questions to the patients referred to them by clinicians with the diagnosis of HF (presented in the appendix to this protocol). In addition, Pittsburg Sleep Quality Index will be applied to all cases.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaies
Data entry staff who will be assigned to the centers for 2 weeks will apply a questionnaire consisting of different questions to the patients referred to them by clinicians with the diagnosis of HF (presented in the appendix to this protocol). In addition, Pittsburg Sleep Quality Index will be applied to all cases.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female patient aged 18 and over
* Signed written informed consent form
Exclusion Criteria
* CRY requiring dialysis
* Serious liver and lung disease
* LVAD/heart transplantation
* HF due to possible temporary cause (myocarditis, peripartum CMP in the first 6 months, takotsubo etc.)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Klinar CRO
OTHER
AstraZeneca Turkey
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara City Hospital
Ankara, , Turkey (Türkiye)
Akdeniz University Medical Faculty
Antalya, , Turkey (Türkiye)
Eskişehir Osmangazi University Medical Faculty
Eskişehir, , Turkey (Türkiye)
Başkent University Istanbul Health Practice and Research Center Hospital
Istanbul, , Turkey (Türkiye)
Dr. Siyami Ersek Chest Cardiac and Vascular Surgery T&R Hospital
Istanbul, , Turkey (Türkiye)
Istanbul University - Cerrahpaşa, Cardiology Institute
Istanbul, , Turkey (Türkiye)
Dokuz Eylül University Medical Faculty
Izmir, , Turkey (Türkiye)
Ege University Medical Faculty
Izmir, , Turkey (Türkiye)
Tepecik Training and Research Hospital
Izmir, , Turkey (Türkiye)
Mersin University Medical Faculty
Mersin, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
K-J019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.